-
Innovation Ranking
Innovation Ranking – GN Store Nord AS
GN Store Nord AS (GN Store) is a provider of medical, professional and consumer audio solutions. The company offers a range of hearing instruments and diagnostic equipment, headsets, and speakerphones. It also offers intelligent headsets, bluetooth headsets and headset for offices, wireless speakers, in-car speakerphones and related accessories. GN Store markets their products under Audigy, Blueparrott, ReSound, Beltone, Interton, Jabra and FalCom brand names. The company has R&D centers are located in Denmark, the US, the Netherlands and China. It...
-
Product Insights
Likelihood of Approval Analysis for Glomerulonephritis
Overview How likely is it that the drugs in Glomerulonephritis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Glomerulonephritis Overview Glomerulonephritis is also known as glomerular nephritis (GN) or glomerular disease....
-
Product Insights
NewHearing Aid Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hearing Aid Devices Pipeline Market Report Overview Hearing aid devices are the electronic device that amplifies and transmits sound, used by people with impaired hearing. The hearing aid devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ezurpimtrostat in Bile Duct Cancer (Cholangiocarcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ezurpimtrostat in Bile Duct Cancer (Cholangiocarcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ezurpimtrostat in Bile Duct Cancer (Cholangiocarcinoma) Drug Details: Ezurpimtrostat (GNS-561)...
-
Company Insights
Innovation and Patenting activity of GN Store Nord AS Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of GN Store Nord AS Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GNS-214-C in Dyslipidemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GNS-214-C in Dyslipidemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GNS-214-C in Dyslipidemia Drug Details: GNS-214-C is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GN-037 in Plaque Psoriasis (Psoriasis Vulgaris)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GN-037 in Plaque Psoriasis (Psoriasis Vulgaris) report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using...
-
Thematic Analysis
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 – Top Themes and Predictions – Thematic Intelligence
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 Theme and Predictions Report Overview Total M&A deal value in the technology, media, and telecom (TMT) sector declined 46% in 2023, compared to the previous year. Software and services accounted for over 48% share of the total M&A deal value in 2023. The ‘Global Tech, Media, And Telecom (TMT) M&A Deals 2023 Theme and Predictions Report’ analyzes the top disruptive themes that drove M&A activity in the technology, media, and telecom (TMT)...
-
Sector Analysis
Denmark Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2028
Denmark Defense Market Report Overview As of 2023, the Denmark defense budget is worth $5.1 billion. The country’s defense budget is set to see high levels of growth, registering a CAGR of more than 4% between 2024 and 2028. The increase in Danish defense expenditure is primarily driven by the government's response to the conflict in Ukraine. Factors expected to accelerate the Denmark's defense market growth during the projected period are rise in the Danish defense sector spending to facilitate...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ezurpimtrostat in Bile Duct Cancer (Cholangiocarcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ezurpimtrostat in Bile Duct Cancer (Cholangiocarcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Ezurpimtrostat in Bile Duct Cancer (Cholangiocarcinoma) Drug Details:Ezurpimtrostat (GNS-561) is under...